A detailed history of Pendal Group LTD transactions in Johnson & Johnson stock. As of the latest transaction made, Pendal Group LTD holds 3,240 shares of JNJ stock, worth $534,016. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,240
Previous 2,547 27.21%
Holding current value
$534,016
Previous $416,000 37.5%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 19, 2023

BUY
$160.2 - $179.79 $111,018 - $124,594
693 Added 27.21%
3,240 $0
Q3 2022

Oct 18, 2022

SELL
$161.33 - $179.52 $6.9 Million - $7.68 Million
-42,799 Reduced 94.38%
2,547 $416,000
Q2 2022

Jul 25, 2022

SELL
$168.19 - $186.01 $2.68 Million - $2.97 Million
-15,946 Reduced 26.02%
45,346 $8.05 Million
Q1 2022

Apr 25, 2022

SELL
$158.14 - $179.59 $8.81 Million - $10 Million
-55,713 Reduced 47.62%
61,292 $10.9 Million
Q4 2021

Jan 18, 2022

BUY
$155.93 - $173.01 $13.4 Million - $14.9 Million
86,142 Added 279.11%
117,005 $20 Million
Q3 2021

Nov 05, 2021

BUY
$161.5 - $179.47 $876,622 - $974,163
5,428 Added 21.34%
30,863 $4.98 Million
Q2 2021

Jul 28, 2021

BUY
$159.48 - $171.07 $537,447 - $576,505
3,370 Added 15.27%
25,435 $4.19 Million
Q1 2021

May 24, 2021

BUY
$153.07 - $170.48 $3.38 Million - $3.76 Million
22,065 New
22,065 $3.63 Million
Q1 2021

May 03, 2021

SELL
$153.07 - $170.48 $4.54 Million - $5.06 Million
-29,653 Closed
0 $0
Q4 2020

Jan 21, 2021

SELL
$137.11 - $157.38 $3.09 Million - $3.55 Million
-22,561 Reduced 43.21%
29,653 $4.67 Million
Q3 2020

Nov 02, 2020

SELL
$140.38 - $153.83 $1.77 Million - $1.95 Million
-12,644 Reduced 19.49%
52,214 $7.77 Million
Q2 2020

Aug 07, 2020

SELL
$128.81 - $155.51 $277,843 - $335,435
-2,157 Reduced 3.22%
64,858 $9.12 Million
Q1 2020

May 04, 2020

SELL
$111.14 - $153.99 $9.27 Million - $12.8 Million
-83,373 Reduced 55.44%
67,015 $8.79 Million
Q4 2019

Feb 06, 2020

BUY
$127.5 - $146.44 $648,847 - $745,233
5,089 Added 3.5%
150,388 $21.9 Million
Q3 2019

Nov 12, 2019

SELL
$126.95 - $142.14 $38,085 - $42,641
-300 Reduced 0.21%
145,299 $18.8 Million
Q2 2019

Aug 01, 2019

SELL
$131.15 - $144.24 $1.52 Million - $1.68 Million
-11,615 Reduced 7.39%
145,599 $0
Q1 2019

May 01, 2019

BUY
$125.72 - $139.79 $668,076 - $742,844
5,314 Added 3.5%
157,214 $0
Q4 2018

Jan 30, 2019

SELL
$122.84 - $147.84 $1.39 Million - $1.68 Million
-11,346 Reduced 6.95%
151,900 $19.6 Million
Q3 2018

Nov 05, 2018

SELL
$121.58 - $142.88 $4.39 Million - $5.16 Million
-36,102 Reduced 18.11%
163,246 $0
Q2 2018

Jul 18, 2018

SELL
$119.4 - $131.76 $919,738 - $1.01 Million
-7,703 Reduced 3.72%
199,348 $0
Q1 2018

May 08, 2018

SELL
$125.1 - $148.14 $93,574 - $110,808
-748 Reduced 0.36%
207,051 $0
Q4 2017

Feb 06, 2018

BUY
$131.22 - $143.62 $3.43 Million - $3.76 Million
26,153 Added 14.4%
207,799 $0
Q3 2017

Nov 01, 2017

BUY
$129.47 - $135.38 $393,200 - $411,149
3,037 Added 1.7%
181,646 $0
Q2 2017

Aug 11, 2017

BUY
N/A
178,609
178,609 $0

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Pendal Group LTD Portfolio

Follow Pendal Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.